Literature DB >> 8132317

Cytokine-mediated indoleamine 2,3-dioxygenase induction in response to Chlamydia infection in human macrophage cultures.

A M Paguirigan1, G I Byrne, S Becht, J M Carlin.   

Abstract

The purpose of this study was to characterize further the events leading to the metabolic degradation of tryptophan in Chlamydia-infected cultures in the absence of added interferon (IFN). Macrophages on coverslips were infected with Chlamydia psittaci, and tryptophan decyclization was determined 24 h later by reverse-phase high-performance liquid chromatography. Tryptophan metabolites cochromatographed with kynurenine and N-formylkynurenine, the end products of tryptophan decyclization by the IFN-inducible enzyme indoleamine 2,3-dioxygenase (IDO). Although chloramphenicol pretreatment completely inhibited chlamydial replication, IDO was stimulated to an extent similar to that in untreated, infected cells. No IDO induction was observed in cells pretreated with cycloheximide even though chlamydial growth was slightly greater than in untreated cells. These results indicate that enhanced tryptophan decyclization was due to induction of IDO. IDO induction was dependent on the size of the chlamydial inoculum. Heat- or UV-inactivated chlamydiae induced significantly less IDO activity than viable chlamydiae. Culture supernatants from Chlamydia-infected macrophages induced IDO activity in a dose-dependent manner, suggesting that a secreted product of infected cells was responsible for IDO induction. A combination of neutralizing antibodies to IFN-alpha and IFN-beta inhibited induction of IDO activity by infected cell culture supernatants. Furthermore, IL-1 enzyme-linked immunosorbent assay results indicated the accumulation of IL-1 beta in the culture medium. Thus, induction of IDO in Chlamydia-infected macrophages reflects the production of cytokines in response to infection and may represent a normal host cell response to control intracellular infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132317      PMCID: PMC186239          DOI: 10.1128/iai.62.4.1131-1136.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Indoleamine 2,3-dioxygenase. Purification and some properties.

Authors:  T Shimizu; S Nomiyama; F Hirata; O Hayaishi
Journal:  J Biol Chem       Date:  1978-07-10       Impact factor: 5.157

2.  Characteristics of interferon induced in vitro and in vivo by a TRIC agent.

Authors:  T C Merigan; L Hanna
Journal:  Proc Soc Exp Biol Med       Date:  1966-06

3.  Rapid separation of tryptophan, kynurenines, and indoles using reversed-phase high-performance liquid chromatography.

Authors:  S Yong; S Lau
Journal:  J Chromatogr       Date:  1979-07-13

4.  Competition between Chlamydia psittaci and L cells for host isoleucine pools: a limiting factor in chlamydial multiplication.

Authors:  T P Hatch
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

5.  Requirements for ingestion of Chlamydia psittaci by mouse fibroblasts (L cells).

Authors:  G I Byrne
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

6.  Parasite-specified phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells.

Authors:  G I Byrne; J W Moulder
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

7.  Lymphokine-mediated microbistatic mechanisms restrict Chlamydia psittaci growth in macrophages.

Authors:  G I Byrne; C L Faubion
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

8.  Chlamydia psittaci elementary body envelopes: ingestion and inhibition of phagolysosome fusion.

Authors:  L G Eissenberg; P B Wyrick; C H Davis; J W Rumpp
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

9.  Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro.

Authors:  W L Beatty; G I Byrne; R P Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  14 in total

1.  Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon.

Authors:  L G Pantoja; R D Miller; J A Ramirez; R E Molestina; J T Summersgill
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

2.  Porcine choroid plexus epithelial cells induce Streptococcus suis bacteriostasis in vitro.

Authors:  Rüdiger A Adam; Tobias Tenenbaum; Peter Valentin-Weigand; Maurice Laryea; Bernd Schwahn; Susanne Angelow; Hans-Joachim Galla; Walter Däubener; Horst Schroten
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

3.  Identifying a role for Toll-like receptor 3 in the innate immune response to Chlamydia muridarum infection in murine oviduct epithelial cells.

Authors:  Wilbert A Derbigny; LaTasha R Shobe; Jasmine C Kamran; Katherine S Toomey; Susan Ofner
Journal:  Infect Immun       Date:  2011-10-17       Impact factor: 3.441

4.  Peptidomic analysis of human peripheral monocytes persistently infected by Chlamydia trachomatis.

Authors:  Birgit Krausse-Opatz; Annette Busmann; Harald Tammen; Christoph Menzel; Thomas Möhring; Nicolas Le Yondre; Cornelia Schmidt; Peter Schulz-Knappe; Henning Zeidler; Hartmut Selle; Lars Köhler
Journal:  Med Microbiol Immunol       Date:  2007-01-06       Impact factor: 3.402

5.  Beta interferon is produced by Chlamydia trachomatis-infected fibroblast-like synoviocytes and inhibits gamma interferon-induced HLA-DR expression.

Authors:  J Rödel; A Groh; H Vogelsang; M Lehmann; M Hartmann; E Straube
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Induction of alpha/beta interferon and dependent nitric oxide synthesis during Chlamydia trachomatis infection of McCoy cells in the absence of exogenous cytokine.

Authors:  A Devitt; P A Lund; A G Morris; J H Pearce
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

7.  Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha.

Authors:  J T Summersgill; N N Sahney; C A Gaydos; T C Quinn; J A Ramirez
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

Review 8.  T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.

Authors:  David J Kahler; Andrew L Mellor
Journal:  Handb Exp Pharmacol       Date:  2009

9.  Potentiation of interferon-mediated inhibition of Chlamydia infection by interleukin-1 in human macrophage cultures.

Authors:  J M Carlin; J B Weller
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma.

Authors:  Illya Tietzel; Christelle El-Haibi; Rey A Carabeo
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.